Advances in Natural Anticancer Formulation
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Physical Pharmacy and Formulation".
Deadline for manuscript submissions: 31 December 2025
Special Issue Editors
Interests: Anticancer; Extract
Interests: bioorganic chemistry and chemistry of natural and physiologically active substances, biochemistry, intracellular redox metabolism, redox-active natural substances, cancer cells metabolism, apoptosis, synergism, medicinal chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Despite numerous improvements in cancer treatment, the disease is still a major cause of high mortality worldwide. Due to the adverse side effects and prohibitive cost of standard therapy, the search for effective, targeted, sparing and affordable cancer therapy is imperative. Natural resources have been and continue to be an exceptional source of new bioactive compounds with undeniable therapeutic benefits. Regardless of their outstanding scientific potential, their clinical application still poses a significant challenge. This Special Issue will review advances in various formulations of natural anticancer drugs, including in vitro, ex vivo and in vivo assessments of their solubility, permeability, distribution, efficacy, and mechanisms of action, as well as the development of improved therapeutic doses, dose–response studies and early preclinical data.
We welcome all researchers for your scientific contributions.
Dr. Georgi G. Antov
Dr. Donika Ivanova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer treatment
- phytocompounds
- drug formulations
- natural-based therapies
- in vitro and ex vivo toxicity evaluation
- in vivo drug sensitivity
- in silico models
- pharmacokinetics/pharmacodynamics
- innovations
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
